These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27247948)

  • 101. Incidence of end-stage renal disease and risk factors for progression of renal dysfunction in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry.
    Iwase M; Ide H; Ohkuma T; Fujii H; Komorita Y; Yoshinari M; Oku Y; Higashi T; Nakamura U; Kitazono T
    Clin Exp Nephrol; 2022 Feb; 26(2):122-131. PubMed ID: 34581896
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Cystatin C and cystatin glomerular filtration rate as markers of early renal disease in Asian Indian subjects with glucose intolerance (CURES-32).
    Surendar J; Anuradha S; Ashley B; Balasubramanyam M; Aravindhan V; Rema M; Mohan V
    Metab Syndr Relat Disord; 2009 Oct; 7(5):419-25. PubMed ID: 19419268
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes.
    Bentata R; Cougnard-Grégoire A; Delyfer MN; Delcourt C; Blanco L; Pupier E; Rougier MB; Rajaobelina K; Hugo M; Korobelnik JF; Rigalleau V
    J Diabetes Complications; 2017 Mar; 31(3):619-623. PubMed ID: 28063765
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.
    Mosenzon O; Wiviott SD; Cahn A; Rozenberg A; Yanuv I; Goodrich EL; Murphy SA; Heerspink HJL; Zelniker TA; Dwyer JP; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Kato ET; Gause-Nilsson IAM; Fredriksson M; Johansson PA; Langkilde AM; Sabatine MS; Raz I
    Lancet Diabetes Endocrinol; 2019 Aug; 7(8):606-617. PubMed ID: 31196815
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Decline in renal function associated with cardiovascular autonomic neuropathy positively coordinated with proteinuria in patients with type 2 diabetes.
    Muramatsu T; Takahashi M; Kakinuma R; Sato T; Yamamoto M; Akazawa M; Tanaka K; Kikuchi T; Kushiyama A
    J Diabetes Investig; 2022 Jan; 13(1):102-111. PubMed ID: 34228899
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Commentary on Intraglumerular dysfunction predicts kidney failure in the type 2 diabetes.
    Wada J
    J Diabetes Investig; 2021 Dec; 12(12):2124-2125. PubMed ID: 34469624
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Association of renal function screening frequency with renal function decline in patients with type 2 diabetes: a real-world study in primary health care.
    Sundqvist H; Heikkala E; Jokelainen J; Russo G; Mikkola I; Hagnäs M
    BMC Nephrol; 2022 Nov; 23(1):356. PubMed ID: 36333795
    [TBL] [Abstract][Full Text] [Related]  

  • 108. PROTECTIVE EFFECTS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS ON PROGRESSION OF DIABETIC RETINOPATHY IN PATIENTS WITH TYPE 2 DIABETES.
    Chung YR; Park SW; Kim JW; Kim JH; Lee K
    Retina; 2016 Dec; 36(12):2357-2363. PubMed ID: 27285457
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Overweight duration in older adults and cancer risk: a study of cohorts in Europe and the United States.
    Arnold M; Freisling H; Stolzenberg-Solomon R; Kee F; O'Doherty MG; Ordóñez-Mena JM; Wilsgaard T; May AM; Bueno-de-Mesquita HB; Tjønneland A; Orfanos P; Trichopoulou A; Boffetta P; Bray F; Jenab M; Soerjomataram I;
    Eur J Epidemiol; 2016 Sep; 31(9):893-904. PubMed ID: 27300353
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Relationship between Estimated Glomerular Filtration Rate and Cardiovascular Mortality in a Japanese Cohort with Long-Term Follow-Up.
    Nagai K; Sairenchi T; Irie F; Watanabe H; Ota H; Yamagata K
    PLoS One; 2016; 11(6):e0156792. PubMed ID: 27272675
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Adverse Impact of Sleep Restriction and Circadian Misalignment on Autonomic Function in Healthy Young Adults.
    Grimaldi D; Carter JR; Van Cauter E; Leproult R
    Hypertension; 2016 Jul; 68(1):243-50. PubMed ID: 27271308
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies.
    Aune D; Keum N; Giovannucci E; Fadnes LT; Boffetta P; Greenwood DC; Tonstad S; Vatten LJ; Riboli E; Norat T
    BMJ; 2016 Jun; 353():i2716. PubMed ID: 27301975
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.
    Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S
    JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    Marso SP; Daniels GH; Brown-Frandsen K; Kristensen P; Mann JF; Nauck MA; Nissen SE; Pocock S; Poulter NR; Ravn LS; Steinberg WM; Stockner M; Zinman B; Bergenstal RM; Buse JB; ;
    N Engl J Med; 2016 Jul; 375(4):311-22. PubMed ID: 27295427
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
    Bijlsma JWJ; Welsing PMJ; Woodworth TG; Middelink LM; Pethö-Schramm A; Bernasconi C; Borm MEA; Wortel CH; Ter Borg EJ; Jahangier ZN; van der Laan WH; Bruyn GAW; Baudoin P; Wijngaarden S; Vos PAJM; Bos R; Starmans MJF; Griep EN; Griep-Wentink JRM; Allaart CF; Heurkens AHM; Teitsma XM; Tekstra J; Marijnissen ACA; Lafeber FPJ; Jacobs JWG
    Lancet; 2016 Jul; 388(10042):343-355. PubMed ID: 27287832
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options.
    Kypridemos C; Allen K; Hickey GL; Guzman-Castillo M; Bandosz P; Buchan I; Capewell S; O'Flaherty M
    BMJ; 2016 Jun; 353():i2793. PubMed ID: 27279346
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial.
    Salisbury C; O'Cathain A; Thomas C; Edwards L; Gaunt D; Dixon P; Hollinghurst S; Nicholl J; Large S; Yardley L; Fahey T; Foster A; Garner K; Horspool K; Man MS; Rogers A; Pope C; Montgomery AA
    BMJ; 2016 Jun; 353():i2647. PubMed ID: 27252245
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study.
    Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Eye Study Group and the Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Study Group
    Diabetes Care; 2016 Jul; 39(7):1089-100. PubMed ID: 27289122
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Intensive Treatment and Severe Hypoglycemia Among Adults With Type 2 Diabetes.
    McCoy RG; Lipska KJ; Yao X; Ross JS; Montori VM; Shah ND
    JAMA Intern Med; 2016 Jul; 176(7):969-78. PubMed ID: 27273792
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Association between Exposure to Smartphones and Ocular Health in Adolescents.
    Kim J; Hwang Y; Kang S; Kim M; Kim TS; Kim J; Seo J; Ahn H; Yoon S; Yun JP; Lee YL; Ham H; Yu HG; Park SK
    Ophthalmic Epidemiol; 2016 Aug; 23(4):269-76. PubMed ID: 27254040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.